Medspa and Dermatology Biologics Supplier in Fort Wayne, Indiana

How medspas and aesthetic practices in this region typically vet a biologics vendor

Medspas operating under physician supervision generally route a new biologics vendor through the supervising physician or medical director, who reviews the supplier's documentation before any product is approved for use in the practice.

Dermatology and plastic surgery practices tend to request the certificate of analysis, donor eligibility summary and, for exosome formats, available particle characterization or full ingredient disclosure before stocking a new product.

Medical director verification through NPI

Precision Biologics ties every account to a National Provider Identifier verified through the NPPES registry. For a medspa, that generally means identifying the supervising or medical director physician rather than the technician or injector delivering a service.

Shipping and storage across formats

Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers and are tracked by lot from release through delivery. The lyophilized Wharton's jelly format and the lyophilized exosome products are shelf-stable and ship at ambient temperature, with storage and reconstitution handling described in the product insert supplied with each lot.

We confirm a receiving contact at the Fort Wayne location before releasing any cryopreserved shipment.

Licensure verification and account support

We ask every Indiana medspa or dermatology account to confirm the supervising physician's active licensure with the Indiana Medical Licensing Board and to review with its own counsel how a given intended use is classified under federal tissue regulations.

These products are not FDA approved or licensed for any disease or condition. Information provided to accounts is for licensed healthcare professionals and is not medical or legal advice; our account team can arrange a physician-level documentation call before a purchasing decision.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.